Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambotek (Beijing Ambotek Biotechnology Co., Ltd.) is a specialized Contract Research Organization (CRO) based in Beijing, China, focusing on high-end biotechnology services. Established in 2005 by Dr. Xiao Fei, the company provides a comprehensive suite of services including custom peptide synthesis, recombinant protein expression, and antibody development. Ambotek serves a global clientele in the pharmaceutical and life sciences industries, offering expertise in complex peptide modifications and various expression systems such as E. coli, yeast, and mammalian cells. The company is recognized for its technical proficiency in molecular biology and its ability to support drug discovery and basic research through high-quality reagent production. As a foundational entity in Dr. Xiao's biotech ventures, it maintains a strong reputation for handling challenging sequences and large-scale protein purification. Its services are integral to the early-stage R&D efforts of numerous biotech and academic partners worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 安博泰克.